FDA Staff Note Deaths in Pfizer Inc. Bone Drug Study

WASHINGTON, Sept 4 (Reuters) - A higher percentage of patients treated with an experimental Pfizer Inc drug for osteoporosis died during a clinical trial compared with a placebo, U.S. drug reviewers said in an analysis released on Thursday.